Difficult Bag Mask Ventilation and Difficult Intubation in Children
NCT ID: NCT02823392
Last Updated: 2019-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
765 participants
OBSERVATIONAL
2008-09-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Factors for Difficult Intubation
NCT04043767
Post Intubation Laryngeal Hazards in Children in the Pediatric Intensive Care Unit
NCT06198634
The Voice Analysis as a Preoperative Prediction Method of a Difficult Airway
NCT04259021
Automated Assessment of Difficult Airway With Facial Recognition Techniques
NCT02022397
I-Gel vs Ambu Laryngeal Mask Airways in Infants and Children Undergoing Surgical Procedures
NCT02938039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Outcome of interest Primary outcomes were to determine the predictors of difficult bag mask ventilation. The difficult bag mask ventilation was defined as the occurrence at least 2 following events which were requiring application of CPAP with opening airway maneuvers, requiring oropharyngeal airway or nasopharyngeal airway, requiring 2- person bag mask ventilation, unable to perform bag mask ventilation or presence of desaturation (SpO2 \< 95%).
Secondary outcome was to find out the association between difficult bag mask ventilation and unexpected difficult laryngoscopy/intubation.
Difficult laryngoscopy was defined as the Cormack-Lehane laryngoscopic view grade 3 or 4. Difficult intubation was defined as the occurrence of at least two of the following: 1) at least three intubation attempts using a conventional laryngoscope blade, either Miller or Macintosh; 2) intubation time (the summation of all attempts from applying a laryngoscope to the endotracheal tube that passed the vocal cords) \>300 seconds; and 3) the occurrence of desaturation (SpO2 \<95%)The intubation time was defined as the time starting from applying laryngoscope to presence of positive capnography wave form. In case of fail intubation, the intubation time started from applying laryngoscope to remove laryngoscope from children's mouth. The total intubation time was the combined timing of each intubation attempts
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DBMV
the occurrence of at least two following events which were requiring application of CPAP with opening airway maneuvers, requiring oropharyngeal airway, requiring two-person bag mask ventilation, unable to perform bag mask ventilation or presence of desaturation (SpO2 \< 95%).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA physical status of 1-3
* came for general anesthesia with oroendotracheal tube intubation
* elective surgery
Exclusion Criteria
* presence of active pulmonary disease
* had preoperative oxygen saturation at room air \< 95%
1 Day
9 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Prince of Songkla University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
maliwan oofuvong
Assistant Professor Maliwan Oofuvong
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
maliwan s oofuvong, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Faculty Of Medicine, Prince Of Songkla University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Prince of Songkla University
Hat Yai, Changwat Songkhla, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DI51
Identifier Type: REGISTRY
Identifier Source: secondary_id
DBMV765
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.